Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-16 4:43 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 6,250 | $0.511 | 95,650 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 6,250 | $0 | 95,650 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-08 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 18,750 | $0.511 | 95,650 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-08 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 18,750 | $0 | 95,650 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:30 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2023-02-16 5:26 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 0 | $0 | 188,150 (Direct) | View |